图表集群引导的多视图社区增强的图表对比学习用于药物向相互作用预测
IEEE journal of biomedical and health informatics
|September 8, 2025
概括
这项研究引入了MneGCL,这是一种新的图形对比学习方法,用于改善药物向相互作用的预测,特别是在稀疏的数据中. 这种方法增强了与药物和目标不太相关的特征表示,提高了预测的准确性.
科学领域:
- 计算生物学是一种计算生物学.
- 生物信息学是一种生物信息学.
- 药物发现 药物发现
背景情况:
- 药物向相互作用 (DTI) 的识别对于药物开发至关重要,包括药物重新定位和预测副作用.
- 现有的计算方法在数据稀疏性方面扎,在这种情况下,药物或目标的已知相互作用很少.
- 解决数据稀疏性是提高DTI预测模型准确性和可靠性的关键.
研究的目的:
- 提出一个多视图社区增强的图形对比学习方法 (MneGCL),以克服DTI预测中的数据稀疏性挑战.
- 充分利用来自毒品和目标的信息,但已知联系有限.
- 增强在异质图中稀疏节点的表示学习能力.
主要方法:
- MneGCL使用相似性网络上的图形集群来分组药物和目标.
- 它通过节点相关性构建语义原型,并使用高斯交互配置文件内核相似性构建表型原型.
- 社区增强的对比学习整合了这些观点,随后是图形自动编码框架用于最终预测.
主要成果:
- 与现有方法相比,MneGCL在三个基准数据集中表现出卓越的性能.
- 在稀疏的DrugBank数据集中观察到显著的改善,平均比基线模型增加2.5%.
- 进一步的实验证实了MneGCL在丰富稀疏连接节点的特征表示中的有效性.
结论:
- 通过利用多视图图形对比学习,MneGCL有效地解决了DTI预测中的数据稀疏性.
- 该方法增强了稀疏节点的表示,从而提高了预测准确度.
- MneGCL为推动药物发现和开发提供了一个有前途的计算方法.
相关概念视频
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Targets for Drug Action: Overview
10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K
Quantitative Aspects of Drug-Receptor Interaction
1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Combined Effects of Drugs: Antagonism
11.6K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.6K
Drug-Receptor Interactions
7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Combined Effects of Drugs: Synergism
6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.8K


